MC
Michael Caspani
OtherActiveManaging Director at BroadOak Capital Partners
Washington, United StatesFounded 2015
11
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Michael Caspani.
Investment Thesis & Strategy
Michael Caspani, as Managing Director at BroadOak Capital Partners, invests in various stages of biotech and fintech companies. BroadOak Capital Partners likely seeks companies with strong growth potential and innovative solutions within these sectors.
Investment Activity
Deals per year over the last 16 years
1
20000
20010
20020
20030
20041
20051
20060
20071
20081
20091
20100
20110
20121
20132
20141
2015Portfolio Companies
Selected investments from their portfolio of 11 companies
B
Bioinformatics
Biotech · Seed, 0
H
Halo Labs
Biotech · Seed, 2015
G
Genomenon
Biotech · Seed, 2014
C
Codex DNA
Biotech · Seed, 2014
s
seqWell
Biotech · Seed, 2013
I
InFuse Holdings
Healthcare · Seed, 2010
B
BioCision
Biotech · Seed, 2009
D
Diagnostic BioSystems
Biotech · Seed, 2008
E
Empire Genomics
Biotech · Seed, 2006
L
LabConnect
Healthcare · Seed, 2005
R
Rubicon Genomics
Biotech · Seed, 2000
Frequently Asked Questions
Michael Caspani focuses on Seed stage investments.